Relapsing-remitting Multiple Sclerosis Treated with Interferon Beta-1a 44 μg from the Onset - a Case Report

As per its globally accepted definition, the cerebrospinal multiple sclerosis is characterized by its dissemination in space and time. Being the most frequent neurological cause of disability in young people of productive age, early treatment initiation is crucial. Here we present a case report of a male patient diagnosed with the multiple sclerosis at 26 years of age. He experienced two relapses during the 24 months since the diagnosis and was indicated for interferon beta-1a treatment. The treatment has been well-tolerated with a minimum of side effects that respond well to symptomatic treatment. Throughout the seven years of treatment, he experienced just one mild relapse without any effect on his ability to work or any restriction to his activities of daily living.